Medispecm Sdn Bhd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medispecm sdn bhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medispecm Sdn Bhd Today - Breaking & Trending Today

Ekuinas acquires 80% stake in pharma ingredients producer Symbiotica

KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) has acquired an 80 per cent stake in Symbiotica Speciality Ingredients Sdn Bhd (Symbiotica), a leading homegrown active pharmaceutical ingredient (API) manufacturer in Southeast Asia (SEA). ....

Kuala Lumpur , Ajoy Prabhu , Sdn Bhd Symbiotica , Seberang Perai , Medispecm Sdn Bhd , Ekuiti Nasional Bhd Ekuinas , Syed Yasir Arafat , Sdn Bhd , Ekuiti Nasional Bhd , Symbiotica Speciality Ingredients Sdn Bhd , Southeast Asia , New Industrial Masterplan , Yasir Arafat , Eagle Cliffe Sdn , Corporate News ,

Ekuinas' total cumulative investment at RM4.4bil in FY21

KUALA LUMPUR: Ekuiti Nasional Bhd’s (Ekuinas) total cumulative investment stood at RM4.4bil in FY21, comprising 70 investments covering 47 direct investments and 23 outsourced programmes which consequently generated a total economic deployment of RM5bil, together with private sector partners. ....

Kuala Lumpur , Medispecm Sdn Bhd , Raja Arshad , Ekuiti Nasional Bhd Ekuinas , Syed Yasir Arafat , Syed Yasir , Arshad Raja , Ekuinas Direct Tranche Iv Fund , Ekuinas Direct Tranche Ii Fund , Ekuiti Nasional Bhd , Ekuinas Direct , Sdn Bhd , Ekuinas Outsourced , Corporate News ,

Ekuinas enters pharma industry with Medispec acquisition


Ekuinas chief executive officer Syed Yasir Arafat Syed Abd Kadir said Ekuinas’ entry into the healthcare and pharmaceutical space was timely as it looked to capitalise on global megatrends and demographic shifts amid the emergence of Covid-19.
KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) made its foray into the pharmaceutical industry with the acquisition of a controlling stake in Medispec (M) Sdn Bhd.
The government-linked private equity fund management company said the acquisition was based on an enterprise value of RM88.5mil.
Ekuinas chief executive officer Syed Yasir Arafat Syed Abd Kadir said Ekuinas’ entry into the healthcare and pharmaceutical space was timely as it looked to capitalise on global megatrends and demographic shifts amid the emergence of Covid-19. ....

Kuala Lumpur , Medispecm Sdn Bhd , Ekuiti Nasional Bhd Ekuinas , Syed Yasir Arafat , Ekuiti Nasional Bhd , Syed Yasir Arafat Abd Kadir , Yasir Arafat , Beng Lee , குவாலா லம்பூர் , சையத் யாசிர் அராபத் , சையத் யாசிர் அராபத் அப்த் கதிர் , யாசிர் அராபத் , பெங் லீ ,